Chennai gets its first wide-bore Silent Scan MRI. New technology (MAGiC) can reduce scan time by as much as 67%

13-Aug-2016

  • GE Healthcare’s Signa Pioneer MRI system with wide-bore Silent Scan and MAGiC is one-of-the the most advanced MRI system available in the country today
  • Gleneagles Global Hospitals, Chennai is the first to make this technology available to people in India. Hospital also introduces advanced PET/CT for cancer diagnosis
  • Tamil Nadu also gets its first MR Elastography for advanced liver imaging  

MRI scans are among the most advanced tools available to image a host of medical conditions that assist the clinician in their diagnosis. However, when people undergoing the MRI scans are questioned, the excessive noise and the duration they have to spend in the machine are reported as two of their biggest concerns areas.

This is where GE Healthcare’s SIGNA PIONEER MRI system is a world apart. It boasts of two innovations: Silent Scan and MAGiC which take patient comfort and convenience to a completely different level. Gleneagles Global Hospitals, a leading healthcare provider in India today inaugurated the country’s first wide-bore 3T Silent Scan MRI with MAGiC at their hospital in Perumbakkam, Chennai. The hospital also inaugurated GE Healthcare’s revolutionary Discovery IQ PET/ CT system which can assist in diagnosis, staging and post treatment monitoring of cancer.

Speaking at the inauguration, Dr. K. Ravindranath, Chairman, Gleneagles Global Health City, Chennai said, “Gleneagles Global Hospitals Group across all its hospitals has always been forefront in introducing new technology for enhancing clinical outcomes. Since inception we have gained the reputation of pioneering and innovating many clinical programs. This has been mainly possible because we believe in investing in new and latest technology that has helped our doctors identify the problem quickly and accurately. The launch today at Gleneagles Global Health City, Chennai is yet another testimony of ours to bring the latest technology for better patient care.”

A conventional MRI scanner produces noise of about 110 decibels (dBA), rivalling noises from a steel mill, an aircraft engine or heavy traffic on our roads. This loud noise causes patient discomfort and distress, which may affect the quality of scan outcome. GE Healthcare addresses this issue with the help of its exclusive wide-bore Silent Scan technology. This enables a less stressful scanning experience. The noise level produced due to Silent Scan is as low as three decibels above ambient noise level (74 dBA) which is significantly lower compared to conventional MRI scanners. The Silent Scan technology -was co-developed in India, leading a silent revolution in MR technology

Magnetic Resonance image compilation (MAGiC) is an exclusive GE Healthcare technology that has been introduced for the first time in India. This helps in reducing scanning time by as much as 67%.

Due to this technology a person can undergo a scan in about 5 mins compared to the traditional 16-20 minutes. MAGiC technology is unique as it allows capture of multiple image contrast of a body part through a single scan, instead of one scan for each contrast, thereby significantly reducing the time for scan. MAGIC also gives doctors the flexibility to retrospectively change the contrast even after the scan is completed and the patient is discharged, thus saving the need of re-scan should there be such a requirement from the doctor.

"At GE Healthcare, we keep people and superior clinical outcomes at the centre of our innovations. Based on feedback from clinicians, technicians and patients, we have introduced Silent Scan and MAGiC technologies which puts patients first, giving them great comfort and convenience, We are delighted to partner with a leading healthcare provider like Gleneagles Global Hospitals to bring these latest technologies for the benefit of people in India/ Chennai”, said Milan Rao, President and CEO, GE Healthcare, India and South Asia.

 

This is designed to enable physicians to evaluate relative liver and muscle tissue stiffness which help physicians make an assessment of tissue health before clinical symptoms become visible. MRE is today fast emerging as a reliable alternative to invasive tissue biopsies, with reduced cost, pain and faster results. MRE cost significantly less, is non-invasive and can give results within 30 mins compared to 72 hours for biopsies.

"Acoustic noise is one the biggest complaints by patients that undergo an MRI scan - especially among elderly and children. This loud noise and in addition, being confined in a small space of conventional MRI scanners can make patients feel claustrophobic and makes it difficult for them to hold still during the scan", said Dr. Scott Atlas, MD, Stanford University, Hoover Institute, California, USA. "If the patient moves, this make the MRI exam very challenging and may effect the quality of the scan. New technologies like Silent Scan and MAGiC, from GE, help to overcome these challenges by making the patient feel more comfortable, relaxed, and reduce the overall scan time, leading to better imaging outcomes."

The value of Positron Emission Tomography–Computed Tomography (PET/CT) for diagnostic imaging in oncology is well established with its capabilities to combine anatomical and functional aspects of the body to provide a complete picture of patient’s health.

Healthcare providers not only want the ability to detect smaller lesions, but also the ability to accurately determine whether the patient is responding to current treatment. When using CT alone, up to six cycles of chemotherapy may be required to determine if the treatment is effective. PET/CT can help speed up treatment, because metabolic changes in a tumor occur more frequently than structural changes. It is a more accurate and reliable solution that can help clinicians determine how well a treatment is working* after as few as 1 to 2 cycles of chemotherapy, and they will be able to tailor the treatment according to individual patient’s response and needs. Thus Molecular imaging using PET/CT is a decisive tool for diagnosis, treatment staging as well as monitoring the progress of treatment, while also reducing overall treatment cost.

GE’s revolutionary DiscoveryTM IQ PET/CT comes with advanced disease detection capabilities as well as measurements to understand patient’s response to cancer treatment. It’s Q.Clear technology provides up to two times improvement in PET quantitative accuracy and image quality. It also has the highest NEMA (National Electrical Manufacturers Association) sensitivity (up to 22 cps/kBq) for high image quality at low doses and the largest axial field-of-view (up to 26 cm) to cover an entire organ for greater patient comfort and care.

Non-alcoholic fatty liver disease (NAFLD) is a distinct liver condition and one of the most common causes of chronic liver disease globally. A study1 done in 2015 indicated the prevalence of the disease to be around 9-35% in the general Indian population, with a higher incidence rate amongst obese and diabetic patients. In Mumbai, the prevalence was reported to be 16.6%,26 while it is reported as 32% in Chennai. 1 Over the years, increasing obesity, hypertension, and diabetes mellitus has also led to higher incidence and prevalence of NAFLD in India. Patients with NAFLD are at increased risk for liver-related morbidity and mortality and also cardiovascular disease risk and increased incidence of diabetes.

India accounts for 8% of the world’s cancer prevalence (~ 3 Million) with over 1 million new cases reported every year and more than 500,000 deaths every year from this condition.2 Breast cancer is the fastest growing in terms of incidence for women and kills the most. Prostate cancer is the fastest-growing in incidence for men, while lung cancer killed the most men.

India also has a very low penetration of radiotherapy centres (cancer centre with radiation facility) with only 0.4 centres/ million population [as against 12.3 in the US, 5.04 in the UK and 1.1 in China] 4 and only 7% of the 640 districts have more than one linear Accelerator. This coupled with limited availability of Oncologist/specialist is limiting access to cancer care for majority of the patients.

Tamil Nadu is no exception: It is the seventh highest in incidence and mortality due to cancer in the country with over 63000 new cases detected every year of which 28,000 die2. Leading cancer types in the state are Lung and stomach cancer (for men) and Breast and Cervix cancer (for women). In recent years lung cancer has overtaken stomach cancer due to better nutrition and increased smoking among men. Breast cancer is increasing due to change in lifestyle and urbanization.

Cancer care infrastructure in Tamil Nadu predominantly exists around Chennai and Kanchipuram districts with a few comprehensive cancer centres spread around the state (Vellore and Coimbatore). However, the rest of the state lacks advanced cancer care infrastructure either for early diagnosis or treatment. Tamil Nadu has only about 42 cancer centres (both private and government) for a population of over 70 million.

Gleneagles Global Hospitals Group is one of India’s fast growing chains of multi super specialty quaternary and tertiary care Hospitals offering healthcare services of international standards. With over 2000 beds, the Group currently has state-of the art hospitals in Hyderabad, Chennai, Bangalore and Mumbai. With the most comprehensive multi-organ transplant services in the country, the Group has carved out a niche for itself by excelling in areas ranging from simple procedures to complex surgeries and multi-organ transplantation services for liver, kidneys, heart and lungs. It has evolved to become a one-stop healthcare destination for people from across the world.

The Gleneagles Global Health City at Perumbakkam, Chennai is the flagship facility of Gleneagles Global Hospitals Group. Gleneagles Global Health City is a 500 bedded facility offering 360-degree advanced quaternary healthcare services with multi-super specialty and multi-organ transplant services. With the finest combination of expertise, experience, state-of-the art technology and well-coordinated team work, every step is aimed at ensuring excellence in patient care.

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com

In India, GE Healthcare is focusing on some of the country’s toughest healthcare challenges– lowering maternal and infant deaths, enabling early detection of cancer and addressing heart diseases early. GE Healthcare pioneered innovation of healthcare imaging technologies ‘In India for India and the world’ to enhance access to quality healthcare at affordable costs to more people.GE Healthcare operates in India through a joint venture- Wipro GE Healthcare Private Limited. For the latest news, please visit http://newsroom.gehealthcare.com

  • http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415196/
  • http://pib.nic.in/newsite/PrintRelease.aspx?relid=106424
  • The Global Burden of Cancer 2013: Published in The Journal of the American Medical Association JAMA Oncology online 28 May 2015
  • http://data.un.org/
  • Atomic Energy Regulatory Board, 2015

* Any clinical/medical treatment and diagnostic decision taken by the clinician/health care professional is at their sole discretion and responsibility.

  • S. Rajan, Communication Leader, GE Healthcare, Rajan.s@ge.com/ +91- 9930109372
  • Sindhu Rajasekhar, Genesis Burson Marsteller, sindhu.rajasekhar@bm.com / +91- 7406891007
  • Phalguna Jandhyala, Gleneagles Global Hospitals, phalguna.jandhyala@globalhospitalsinida.com/ +91 – 8374211066
  • Raj Rishi, Gleneagles Global Health City, rajarishi.r@globalhospitalsindia.com/ +91-9566211333

Latest Press Releases

BGS Gleneagles Global Hospital Performs Successful Liver Transplant to Treat Acute Liver Failure


Read more

BGS Gleneagles Global Hospital Performs Successful Use of Spy Glass to Treat Large Liver Tube Gall Stones without Surgery


Read more

Global Hospitals Launches Institute of Liver Diseases, HPB Surgery and Transplantation for Patients in Mumbai


Read more

Gleneagles Global Hospital, Chennai conducts unique Focus Group workshop for its nursing staff under AHPI


Read more

Global Hospitals - Now a Destination for Heart Transplantation


Read more

Rare Renal transplant by Global Hospitals surgeons


Read more

Gleneagles Global Hospitals launches a new facility in Bengaluru


Read more

Gleneagles Global Health City successfully removes the Largest Liver Tumor ever reported, weighing 6.2 Kilograms


Read more

BGS Gleneagles Global Hospitals pioneers day care Bone Marrow Transplant program in Bangalore


Read more

Gleneagles Global Health City launches ‘CONNECT’ – A Brain Tumour Support Group


Read more

Advanced Heart Failure Treatment Program


Read more

Health Minister C. Laxma Reddy visits Gleneagles Global Hospitals, Lakdikapul to appreciate the team of Surgeons for 4 successful heart transplantations in a month


Read more

Global Hospitals Pioneers High Tech Shoulder Replacement Surgery


Read more

Longest Distance haul of donated Lungs in India


Read more

Donated Heart flown down to Chennai to give a second lease of life to an ailing patient


Read more

Organs flown from Nagpur saves 2 lives in Mumbai and Pune respectively First heart Transplant conducted at Global Hospitals Mumbai


Read more

Gleneagles Global Hospitals Bangalore drives breast cancer awareness


Read more

Gleneagles Global Health City held the 3rd Neurosciences Master Class that focused on Pediatric Neuro Care


Read more

Gleneagles Global Hospitals boosts the state’s heart and lung transplant scenario with the launch of their new program in Karnataka


Read more

Blueair and Global Hospitals come together to raise awareness on the ill effects of air pollution


Read more

Launch of Pantai-Gleneagles Global Liver Programme To Benefit Malaysians Seeking Treatment and Transplant in India


Read more

Hon’ble Chief Minister K. Palaniswami inaugurated the 8th edition of the MCLD


Read more

Global Hospitals makes its first move in its unique partnership with ‘Walk with a Doc’


Read more

On International Women’s Day, Gleneagles Global Health City launched ‘CECURA’ – An Integrated Uro - Gynecology Unit in a Tertiary Care Hospital


Read more

Dr Ajay Bakshi is now CEO-Designate, India Operations Division, ParkwayPantai


Read more

21 year old boy from Mumbai undergoes a successful bypass surgery after developing a heart condition due to bad dietary habits


Read more

Tamil Nadu gets its 1st Advanced Treatment Centre for Epilepsy at Gleneagles Global Health City


Read more

BGS Gleneagles Global Hospitals launches emergency whatsapp number


Read more

Global Hospitals, Mumbai successfully completes 250 liver transplants


Read more

BGS Gleneagles Global Hospitals successfully conducts two consecutive bilateral lung transplants in one week


Read more

Gleneagles Global Hospitals organises bike rally, to raise awareness of road safety


Read more

Global Hospital performs a successful liver transplant on lightest baby weighing 4.7 Kg from Western India


Read more

One Year Old Boy Undergoes Successful Live Liver Transplant At Gleneagles Global Health City


Read more